Questions before booking? Text us at 561-216-7066
Beyond Concierge Healthcare logo Text or Call: 561-216-7066

Peptide Therapy · Learning Library

What Is Tesamorelin? How It Targets Abdominal Fat

An educational overview of tesamorelin, an FDA-approved growth hormone releasing hormone analog studied for deep belly fat.

Tesamorelin in short
  • Tesamorelin is a lab-made version of growth hormone releasing hormone with a small change that makes it more stable in the body.
  • It binds to GHRH receptors in the pituitary and prompts the body to release its own growth hormone.
  • Tesamorelin has solid human trial data for its approved use, showing meaningful reductions in visceral fat.
  • Tesamorelin is FDA-approved, under the brand name Egrifta, to reduce excess abdominal fat in adults with HIV-associated lipodystrophy.

What Tesamorelin is

Tesamorelin is a lab-made version of growth hormone releasing hormone with a small change that makes it more stable in the body.

How it works in the body

  • It binds to GHRH receptors in the pituitary and prompts the body to release its own growth hormone.
  • Raised growth hormone and IGF-1 levels can shift how the body stores and burns fat.
  • Its best-studied effect is on visceral fat, the deep fat around the organs.

What it's commonly used for

Tesamorelin is FDA-approved, under the brand name Egrifta, to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Outside of that use, people are interested in it for belly fat and body composition.

What the research shows

Tesamorelin has solid human trial data for its approved use, showing meaningful reductions in visceral fat. Research outside that group is smaller.

Safety and side effects

Known side effects include joint pain, injection-site reactions, swelling and higher blood sugar, so a provider would check labs and history first.

Talk it through with a provider

If you're curious whether peptides fit into your health goals, a licensed provider can look at your history and labs and talk through the evidence, the risks and your options.

Questions

Tesamorelin: frequently asked questions

What is Tesamorelin?

Tesamorelin is a lab-made version of growth hormone releasing hormone with a small change that makes it more stable in the body.

How does Tesamorelin work?

It binds to GHRH receptors in the pituitary and prompts the body to release its own growth hormone. Raised growth hormone and IGF-1 levels can shift how the body stores and burns fat.

What is Tesamorelin commonly used for?

Tesamorelin is FDA-approved, under the brand name Egrifta, to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Outside of that use, people are interested in it for belly fat and body composition.

Is Tesamorelin FDA-approved?

Yes, for one specific use. Tesamorelin is FDA-approved, under the brand name Egrifta, to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Other uses are off-label, so talk with a licensed provider before starting any treatment.

What are the side effects of Tesamorelin?

Known side effects include joint pain, injection-site reactions, swelling and higher blood sugar, so a provider would check labs and history first.

This article is general education and isn't medical advice, and it isn't a recommendation to use any substance. Information about research and regulations can change. Talk with a licensed healthcare provider before starting any treatment.

CallText UsBook Now